Leaflet RAPIBLOC 300mg powder for solution for infusion
Indicated for: cardiac arrhythmias
Route of administration: infusion
Substance: landiolol (antiarrhythmic)
ATC: C07AB14 (Cardiovascular system | Beta blocking agents | Beta blocking agents, selective)
This medicine may increase the risk of heart rhythm disturbances.
Landiolol is a medication used to control supraventricular tachycardia and perioperative hypertension. It is an ultra-selective beta-blocker with rapid action that reduces heart rate and blood pressure by blocking beta-1 adrenergic receptors.
The medication is administered intravenously, usually in a hospital setting, under the supervision of a doctor. Due to its rapid onset and short duration of effect, it is ideal for use in acute situations.
Side effects may include low blood pressure, bradycardia, dizziness, or nausea. In rare cases, severe allergic reactions or heart failure may occur.
Patients should inform their doctor about any other medications they are taking and be closely monitored during treatment. Pregnant or breastfeeding women should consult a specialist before use.
General data about RAPIBLOC 300mg
- Substance: landiolol
- Date of latest medicines list: 01-06-2026
- Product code: W66026001
- Concentration: 300mg
- Pharmaceutical form: powder for solution for infusion
- Quantity: 1
- Product type: Original
- Price: 1613.53 RON
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Pharmaceutical forms available for landiolol
Concentrations available for landiolol
- 20mg/2ml
- 300mg
- 600mg